Putting the glomerulus back together: Per aspera ad astra ("a rough road leads to the stars")

Kidney International

Volumn 85, Issue 5, 2014, Pages 991-998

  Schlöndorff, Detlef ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; SIGNAL PEPTIDE;

APOL1 GENE; CELL ANCHORAGE; CELL DAMAGE; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; DNA MODIFICATION; ENDOTHELIUM CELL; FOCAL GLOMERULOSCLEROSIS; GENE; GENE MUTATION; GENETIC MANIPULATION; GLOMERULAR FILTRATION BARRIER; GLOMERULOPATHY; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION; HUMAN; KIDNEY DEVELOPMENT; KIDNEY REGENERATION; MESANGIUM CELL; MOLECULAR CLONING; MOLECULAR INTERACTION; MULTIPHOTON MICROSCOPY; NEPHROTIC SYNDROME; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN MODIFICATION; REGENERATIVE ABILITY; REGENERATIVE MEDICINE; REVIEW; TISSUE REGENERATION; ANIMAL; CELL COMMUNICATION; GENETIC PREDISPOSITION; GENETICS; GLOMERULUS FILTRATION RATE; HEREDITY; KIDNEY DISEASE; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; CELL COMMUNICATION; ENDOTHELIAL CELLS; GENETIC PREDISPOSITION TO DISEASE; GLOMERULAR FILTRATION RATE; HEREDITY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY DISEASES; KIDNEY GLOMERULUS; MESANGIAL CELLS; MUTATION; PODOCYTES; SIGNAL TRANSDUCTION;

EID: 84899729677     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.51     Document Type: Editorial

References (84)

1. Miner JH. The glomerular basement membrane. Exp Cell Res 2012; 318: 973-978.
2. Abrahamson DR. Role of the podocyte (and glomerular endothelium) in building the GBM. Semin Nephrol 2012; 32: 342-349.
3. Sachs N, Sonnenberg A. Cell-matrix adhesion of podocytes in physiology and disease. Nat Rev Nephrol 2013; 9: 200-210.
4. Patrakka J, Tryggvason K. New insights into the role of podocytes in proteinuria. Nat Rev Nephrol 2009; 5: 463-468.
5. Greka A, Mundel P. Cell biology and pathology of podocytes. Annu Rev Physiol 2012; 74: 299-323.
6. Vaughan MR, Quaggin SE. How do mesangial and endothelial cells form the glomerular tuft? J Am Soc Nephrol 2008; 19: 24-33.
7. Satchell S. The role of the glomerular endothelium in albumin handling. Nat Rev Nephrol 2013; 9: 717-725.
8. Haraldsson BS. The endothelium as part of the integrative glomerular barrier complex. Kidney Int 2014; 85: 8-11.
9. Obeidat M, Obeidat M, Ballermann BJ. Glomerular endothelium: a porous sieve and formidable barrier. Exp Cell Res 2012; 318: 964-972.
10. Schlöndorff D, Banas B. The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 2009; 20: 1179-1187.
11. Grahammer F, Schell C, Huber TB. The podocyte slit diaphragm-from a thin grey line to a complex signalling hub. Nat Rev Nephrol 2013; 9: 587-598.
12. Eremina V, Sood M, Haigh J et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707-716.
13. Eremina V, Cui S, Gerber H et al. Vascular endothelial growth factor A signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol 2006; 17: 724-735.
14. Sison K, Eremina V, Baelde H et al. Glomerular structure and function require paracrine, not autocrine, VEGFVEGFR-2 signaling. J Am Soc Nephrol 2010; 21: 1691-1701.
15. Lindahl P, Hellstrom M, Kalen M et al. Paracrine PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in kidney glomeruli. Development 1998; 125: 3313-3322.
16. Leveen P, Pekny M, Gebre-Medhin S et al. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 1994; 8: 1875-1887.
17. Soriano P. Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice. Genes Dev 1994; 8: 1888-1896.
18. Burghardt T, Kastner J, Suleiman H et al. LMX1B is essential for the maintenance of differentiated podocytes in adult kidneys. J Am Soc Nephrol 2013; 24: 1830-1848.
19. Davis B, Dei Cas A, Long DA et al. Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol 2007; 18: 2320-2329.
20. Salmon AH, Neal CR, Sage LM et al. Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyx. Cardiovasc Res 2009; 83: 24-33.
21. Satchell SC, Harper SJ, Tooke JE et al. Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 2002; 13: 544-550.
22. Jeansson M, Gawlik A, Anderson G et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011; 121: 2278-2289.
23. Bernstein J, Cheng F, Roszka J. Glomerular differentiation in metanephric culture. Lab Invest 1981; 45: 183-190.
24. Nagata M, Watanabe T. Podocytes in metanephric organ culture express characteristic in vivo phenotypes. Histochem Cell Biol 1997; 108: 17-25.
25. Weavers H, Prieto-Sanchez S, Grawe F et al. The insect nephrocyte is a podocyte-like cell with a filtration slit diaphragm. Nature 2009; 457: 322-326.
26. Ostendorf T, Kunter U, Eitner F et al. VEGF(165) mediates glomerular endothelial repair. J Clin Invest 1999; 104: 913-923.
27. Haraldsson B, Nystrom J, Deen WM. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol Rev 2008; 88: 451-487.
28. Friden V, Oveland E, Tenstad O et al. The glomerular endothelial cell coat is essential for glomerular filtration. Kidney Int 2011; 79: 1322-1330.
29. Dane MJ, van den Berg BM, Avramut MC et al. Glomerular endothelial surface layer acts as a barrier against albumin filtration. Am J Pathol 2013; 182: 1532-1540.
30. Kanwar YS, Linker A, Farquhar MG. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol 1980; 86: 688-693.
31. Singh A, Satchell SC, Neal CR et al. Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J Am Soc Nephrol 2007; 18: 2885-2893.
32. Salmon AH, Ferguson JK, Burford JL et al. Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. J Am Soc Nephrol 2012; 23: 1339-1350.
33. Eremina V, Quaggin SE. Biology of anti-angiogenic therapy-induced thrombotic microangiopathy. Semin Nephrol 2010; 30: 582-590.
34. Eremina V, Jefferson JA, Kowalewska J et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008; 358: 1129-1136.
35. Maynard SE, Min JY, Merchan J et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
36. Caulfield JP, Farquhar MG. The permeability of glomerular capillaries to graded dextrans. Identification of the basement membrane as the primary filtration barrier. J Cell Biol 1974; 63: 883-903.
37. Smithies O. Why the kidney glomerulus does not clog: a gel permeation/diffusion hypothesis of renal function. Proc Natl Acad Sci USA 2003; 100: 4108-4113.
38. Brenner BM, Livine SA. Brenner and Rector's The Kidney, 2-vol. set. W.B. Saunders: Philadelphia, PA, 1999.
39. Salmon AH, Satchell SC. Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. J Pathol 2012; 226: 562-574.
40. Hausmann R, Kuppe C, Egger H et al. Electrical forces determine glomerular permeability. J Am Soc Nephrol 2010; 21: 2053-2058.
41. Zallocchi M, Johnson BM, Meehan DT et al. a1b1 integrin/ Rac1-dependent mesangial invasion of glomerular capillaries in Alport syndrome. Am J Pathol 2013; 183: 1269-1280.
42. Floege J, Eitner F, Alpers CE. A new look at plateletderived growth factor in renal disease. J Am Soc Nephrol 2008; 19: 12-23.
43. Kopp JB. An expanding universe of FSGS genes and phenotypes: LMX1B mutations cause familial autosomal dominant FSGS lacking extrarenal manifestations. J Am Soc Nephrol 2013; 24: 1183-1185.
44. Pollak MR, Genovese G, Friedman DJ. APOL1 and kidney disease. Curr Opin Nephrol Hypertens 2012; 21: 179-182.
45. Brown EJ, Pollak MR, Barua M. Genetic testing for nephrotic syndrome and FSGS in the era of nextgeneration sequencing. Kidney Int advance online publication, 5 March 2014, doi:10.1038/ki.2014.48.
46. D'Agati VD. Pathobiology of focal segmental glomerulosclerosis: new developments. Curr Opin Nephrol Hypertens 2012; 21: 243-250.
47. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 2011; 365: 2398-2411.
48. Wiggins RC. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 2007; 71: 1205-1214.
49. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
50. Kriz W. Glomerular diseases: podocyte hypertrophy mismatch and glomerular disease. Nat Rev Nephrol 2012; 8: 618-619.
51. Fukuda A, Chowdhury MA, Venkatareddy MP et al. Growthdependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol 2012; 23: 1351-1363.
52. Yang HC, Liu SJ, Fogo AB. Renal regeneration in mammals. Nephron (in press).
53. Pichaiwong W, Hudkins KL, Wietecha T et al. Reversibility of structural and functional damage in a model of advanced diabetic nephropathy. J Am Soc Nephrol 2013; 24: 1088-1102.
54. Wanner N, Hartleben B, Herbach N et al. Unraveling the role of podocyte turnover in glomerular aging and injury. J Am Soc Nephrol advance online publication, 9 January 2014, doi:10.1681/ASN.2013050452.
55. Lasagni L, Romagnani P. Basic research: Podocyte progenitors and ectopic podocytes. Nat Rev Nephrol 2013; 9: 715-716.
56. Satchell SC, Tooke JE. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 2008; 51: 714-725.
57. Nieuwdorp M, Mooij HL, Kroon J et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006; 55: 1127-1132.
58. Siddiqi FS, Advani A. Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes. Diabetes 2013; 62: 3647-3655.
59. Weil EJ, Lemley KV, Mason CC et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int 2012; 82: 1010-1017.
60. Caramori ML, Parks A, Mauer M. Renal lesions predict progression of diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol 2013; 24: 1175-1181.
61. Gnudi L. Cellular and molecular mechanisms of diabetic glomerulopathy. Nephrol Dial Transplant 2012; 27: 2642-2649.
62. Hodgin JB, Nair V, Zhang H et al. Identification of crossspecies shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes 2013; 62: 299-308.
63. Sun YB, Qu X, Zhang X et al. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy. PLoS One [online] 2013; 8: e55027.
64. Forbes MS, Thornhill BA, Park MH et al. Lack of endothelial nitric-oxide synthase leads to progressive focal renal injury. Am J Pathol 2007; 170: 87-99.
65. Zhao HJ, Wang S, Cheng H et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. J Am Soc Nephrol 2006; 17: 2664-2669.
66. Nakagawa T, Sato W, Glushakova O et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. J Am Soc Nephrol 2007; 18: 539-550.
67. Kanetsuna Y, Takahashi K, Nagata M et al. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol 2007; 170: 1473-1484.
68. Dai C, Saleem MA, Holzman LB et al. Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria. Kidney Int 2010; 77: 962-973.
69. Levine RJ, Maynard SE, Qian C et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683.
70. Levine RJ, Lam C, Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005.
71. Clement LC, Avila-Casado C, Mace C et al. Podocytesecreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 2011; 17: 117-122.
72. Sugimoto H, Hamano Y, Charytan D et al. Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 2003; 278: 12605-12608.
73. Wnuk M, Hlushchuk R, Janot M et al. Podocyte EphB4 signaling helps recovery from glomerular injury. Kidney Int 2012; 81: 1212-1225.
74. Daehn I, Casalena G, Zhang T et al. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis. J Clin Invest advance online publication, 3 March 2014, doi:10.1172/ JCI71195.
75. O'Neill AC, Ricardo SD. Human kidney cell reprogramming: applications for disease modeling and personalized medicine. J Am Soc Nephrol 2013; 24: 1347-1356.
76. Takasato M, Er PX, Becroft M et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat Cell Biol 2014; 16: 118-126.
77. Taguchi A, Kaku Y, Ohmori T et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 2014; 14: 53-67.
78. Obokata H, Wakayama T, Sasai Y et al. Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature 2014; 505: 641-647.
79. Kumar V, Westra HJ, Karjalainen J et al. Human diseaseassociated genetic variation impacts large intergenic non-coding RNA expression. PLoS Genet [online] 2013; 9: e1003201.
80. Orom UA, Derrien T, Beringer M et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010; 143: 46-58.
81. Kato M, Park JT, Natarajan R. MicroRNAs and the glomerulus. Exp Cell Res 2012; 318: 993-1000.
82. Gebeshuber CA, Kornauth C, Dong L et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1. Nat Med 2013; 19: 481-487.
83. Hackl MJ, Burford JL, Villanueva K et al. Tracking the fate of glomerular epithelial cells in vivo using serial multiphoton imaging in new mouse models with fluorescent lineage tags. Nat Med 2013; 19: 1661-1666.
84. Tao J, Polumbo C, Reidy K et al. A multicolor podocyte reporter highlights heterogeneous podocyte changes in focal segmental glomerulosclerosis. Kidney Int advance online publication, 27 November 2013, doi:10.1038/ ki.2013.463.